Work

7001 ORAL Abiraterone Acetate Improves Functional Status in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Post-docetaxel – Results From the COU-AA-301 Phase 3 Study

Year: 2011

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(11)71952-9

Authors: S. Harland, J.S. de Bono, C.M. Haqq, J.N. Staffurth, Y. Hao, D. Gagnon, C. Liu, C.N. Sternberg, A. Molina, H.I. Scher

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1974967161

FWCI: 2.714

Cites:

Cited by: 11

Related to: 10